« Previous article
What's on Show a...

12th November 2019  Editorial by: rapidmicrobiology staff writer

Identifying the Microbiome - a rapidmicrobiology Special Focus


Browse through our selected highlights of products and service providers that will help you identify the whole microbiome in your samples; highlights include

  • our interview with Dr. Fiona Crispie from APC Microbiome Ireland, who gives us some great easy-to-understand explanations of the difference between 16S sequencing, shotgun metagenomics, whole-genome sequencing, and transcriptomics
  • in addition, we find out from Dr. Thomas Brefort, Eurofins Genomics, what impact their NovaSeq6000 has had on their NGS services and what the future of this technology looks like
  • plus win $25,000 worth of cultivation and isolation for your microbiome project
Interview with Dr. Fiona Crispie of APC Microbiome Ireland​

APC Microbiome

Dr. Fiona Crispie runs Ireland's largest Next-Generation Sequencing platform at APC Microbiome Ireland. She talks to rapidmicrobiology.com about microbiome sequencing methods and the interesting microbiome projects her team are involved in. 

FindoutMoreRMB

 

Identify and Understand the Microbiome with NCIMB

Identify and Understand the Microbiome with NCIMB

NCIMB’s next-generation sequencing and bioinformatics services for bacterial community analysis allow you to identify and understand the full population present within a microbiome sample. 

FindoutMoreRMB

 

Eurofins Genomics NGS Services now Includes Illumina's Latest Sequencing Platform​

Eurofins Genomics NGS Services

rapidmicrobiology asks Dr. Thomas Brefort, Business Unit Manager for NGS at Eurofins Genomics, and one of the Managing Directors of Eurofins' sequencing division, about the impact that the NovaSeq6000 has had on their NGS services and what the future of this technology looks like.

FindoutMoreRMB

 

Long-Read Sequencing Interrogates Every 16S HVR in the Microbiome

Loop Genomics

Loop Genomics deploys a new highly-affordable long-read sequencing service for the microbiome that interrogates single continuous 16S molecules (v1-v9). This long-read sequencing technology has applications in plant, animal, and microbial genomics.

FindoutMoreRMB

 

Win $25,000 Worth of Cultivation And Isolation for Your Microbiome Project

Scientific Challenge

The ‘Microbiome Challenge Program’ offers researchers the chance to have their microbiome project isolated, cultivated, and sequenced using high-throughput GALT and COSMOS ID technologies. 

FindoutMoreRMB

 

Clinical Microbiomics A/S: Your Expert Partner for Microbiome Analysis

Clinical Microbiome

Clinical Microbiomics A/S is the world´s leading provider of advanced microbiome analysis covering the entire workflow from extracting DNA, sequencing, profiling, and biostatistics and linking the microbiome to relevant clinical parameters. 

FindoutMoreRMB

 

How to Diagnose the Loss of Gut Bacterial Diversity?

How to Diagnose the Loss of Gut Bacterial Diversity

The French start-up Luxia Scientific provides 1test1™, a diagnostic kit for the loss of gut microbial diversity for people with gut disorders or wishing to check their health, through the identification of bacterial dysbiosis. 

FindoutMoreRMB

 

Diversigen to Supply Metagenomics and Microbiome Analysis Services for IBD Research - Diversigen will be a central lab for the generation of high-quality microbiome data for the IBD Plexus® platform, a first-of-its-kind research information exchange platform designed to centralize data and biosamples from diverse research initiatives for IBD patients.

OraSure Expands with Pioneering Microbiome Companies - OraSure Technologies have acquired microbiome sequencing pioneers Diversigen for $12 million. OraSure in recent times have been building up their portfolio for clients with CoreBiome and DNA Genotek already under their belt.

Mark Bamforth’s New $82m Microbiome Venture with ThermoFisher - Arranto bio have secured $82million in funding and formed a strategic partnership with ThernoFisher to become the best-in-class microbiome contract development and manufacturing organization.

Discover more about the Microbiome at the following events:

Microbiome Movement Drug Development Europe - London, United Kingdom 4-6 February 2020

Join leading scientists from the biopharmaceutical and academic community to pursue the causal role of the microbiome in disease, and help create a new generation of microbiome-targeted therapeutics with predictable modes of action and consistent clinical outcomes.

3rd Microbiome Movement Gut-Brain Axis Summit - Boston, United Kingdom, 3-5 December 2020

Join professionals from the pharmaceutical, nutritional and academic community to discover and clinically validate microbiome gut-brain axis pathways to transform treatment strategies for patients with neurological disorders.


    

Tags:

Date Published: 12th November 2019


View full company details